Lidoflex
FDA Label NDC 69313-635

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Naimco, Inc. Dba Richmar, Inc. for the product Lidoflex (NDC 69313-635). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding primary package legal copy and artwork including active ingredients, inactive ingredients, instructions for use, lidocaine 4% patch, lidoflex secondary packaging commercial display, warnings, dosage & administration, inactive ingredients, indications & usage, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.